Evelyn Partners Group Ltd’s Gilead Sciences GILD Stock Holding History

Evelyn Partners Group Ltd’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$96.8K	Buy	+766	New	+$101K	﹤0.01%	321

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Evelyn Partners Group Ltd's GILD Position: Q2 2026 in Review

Evelyn Partners Group Ltd opened a new position in Gilead Sciences (GILD) in Q2 2026: 766 shares worth $96.8K. The stake represents ﹤0.01% of the portfolio and ranks #321 among its holdings.

1,412 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Evelyn Partners Group Ltd held 766 shares of Gilead Sciences worth $96.8K as of Q2 2026.
Gilead Sciences was a new Evelyn Partners Group Ltd position in Q2 2026.
Gilead Sciences made up ﹤0.01% of Evelyn Partners Group Ltd's portfolio in Q2 2026, its #321 holding.
1,412 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Evelyn Partners Group Ltd's 13F filing for Q2 2026, filed 7 Aug 2026.